Science Daily - Heart Disease
APRIL 11, 2024
A drug approved to treat pulmonary arterial hypertension may be effective at managing hypertension and end-organ damage in patients with sickle cell disease, according to a new study. Preliminary efficacy data suggested the medication might improve heart function.
Dr. Smith's ECG Blog
AUGUST 14, 2023
The electronic medical record revealed that this patient had known history including pulmonary hypertension, sickle cell disease with frequent transfusions, CHF, restrictive lung disease with chronic hypoxic respiratory failure on oxygen at home, CKD, OSA on nightly BIPAP, and chronic pulmonary embolism.
Stroke Journal
FEBRUARY 1, 2024
Introduction:Cerebral aneurysm frequency in sickle cell disease (SCD) is higher than in the general population. Systolic blood pressure and Hb levels were not different in SCD participants with and without aneurysms, p=0.074 and p=0.358, respectively. In the SCD aneurysm group, median age was older, 30.9
Society of Thoracic Surgeons - Research
APRIL 20, 2023
Laurie Shroyer Geographic Variations in Lung Cancer Lobectomy Outcomes: The General Thoracic Surgery Database The Annals of Thoracic Surgery November 2017 Michael Durheim Mortality and Respiratory Failure After Thoracoscopic Lung Biopsy for Interstitial Lung Disease The Annals of Thoracic Surgery August 2017 Daniel Boffa Surgically Managed Clinical (..)
Society of Thoracic Surgeons - Research
APRIL 20, 2023
Laurie Shroyer Geographic Variations in Lung Cancer Lobectomy Outcomes: The General Thoracic Surgery Database The Annals of Thoracic Surgery November 2017 Michael Durheim Mortality and Respiratory Failure After Thoracoscopic Lung Biopsy for Interstitial Lung Disease The Annals of Thoracic Surgery August 2017 Daniel Boffa Surgically Managed Clinical (..)
Expert insights. Personalized for you.
75 
Let's personalize your content